{
    "organizations": [],
    "uuid": "b80d8acbf6551668598adb05c9f43c5c4e8eafb7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sangamo-therapeutics-q4-loss-per-s/brief-sangamo-therapeutics-q4-loss-per-share-0-15-idUSASB0C6YA",
    "ord_in_thread": 0,
    "title": "BRIEF-Sangamo Therapeutics Q4 Loss Per Share $0.15",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Sangamo Therapeutics Inc:\n* SANGAMO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 REVENUE $13.1 MILLION VERSUS $8.9 MILLION * Q4 LOSS PER SHARE $0.15 * Q4 EARNINGS PER SHARE VIEW $-0.18, REVENUE VIEW $11.4 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T20:16:00.000+02:00",
    "crawled": "2018-02-23T15:36:33.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sangamo",
        "therapeutic",
        "inc",
        "sangamo",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "revenue",
        "million",
        "versus",
        "million",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}